Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Toxicology ; 134(1): 79-88, 1999 May 03.
Article in English | MEDLINE | ID: mdl-10413190

ABSTRACT

Recently we observed a suppressed delayed-type hypersensitivity (DTH) response to bovine serum albumin (BSA) in the 4-5-month-old offspring of F344 rat dams receiving as little as 1.0 microg 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)/kg on gestational day (GD) 14. This study was designed to characterize better this suppression of the DTH response. First, the persistence of the DTH suppression was determined by measuring the DTH response to BSA in the offspring of dams dosed orally with 3.0 microg TCDD/kg on GD14 as well as in age-matched controls at 4, 8, 12 and 19 months of age. TCDD significantly suppressed the males' DTH response through 19 months of age. While the females' DTH response was reduced at 8, 12 and 19 months, significant suppression was observed only at 4 months of age. Secondly, the lowest maternal dose of TCDD that produced DTH suppression was determined by measuring the DTH response to BSA in the 4- and 14-month-old offspring of dams dosed orally with 0, 0.1, 0.3 or 1.0 microg TCDD/kg on GD14. In the males, suppression was observed at a maternal dose as low as 0.1 microg TCDD/kg at 14 months of age, while a maternal dose of 0.3 microg TCDD/kg was necessary to cause suppression in the 14-month-old females. Both males and females were more sensitive to the suppression at 14 months of age than at 4 months of age. Lastly, the DTH response to a second antigen was examined by measuring the DTH response to either BSA or keyhole limpet hemocyanin (KLH) in the 5- or 4-month-old male offspring, respectively, of dams dosed orally with either 0 or 3.0 microg TCDD/kg on GD14. The DTH response to both antigens was suppressed significantly. Phenotypic analysis was performed on thymus and lymph node suspensions. Significant effects in the thymus included an increased percentage of gammadelta TCR+ cells and a decreased percentage of gammadelta TCR+/CD4- CD8- and MHCI- MHCII- cells. In the popliteal lymph node draining the BSA-injected footpad, there was a decreased percentage of gammadelta TCR+ and MHCI- MHCII- cells and an increased percentage of MHCI+ cells. In conclusion, the suppression of the DTH response associated with perinatal TCDD exposure is persistent through late adulthood, occurs at a low dose (i.e. 0.1 microg TCDD/kg) to the dam, and is more pronounced in males than females. While phenotypic analysis identified differences in subsets of thymocytes and lymph node cells between control and TCDD exposed offspring, no clear correlations were established between altered subpopulations and suppressed DTH responses.


Subject(s)
Fetus/drug effects , Hypersensitivity, Delayed/prevention & control , Polychlorinated Dibenzodioxins/toxicity , Animals , Female , Histocompatibility Antigens Class I/analysis , Histocompatibility Antigens Class II/analysis , Male , Rats , Rats, Inbred F344 , Receptors, Antigen, T-Cell, gamma-delta/analysis , T-Lymphocyte Subsets/drug effects
2.
Toxicology ; 122(3): 219-28, 1997 Oct 19.
Article in English | MEDLINE | ID: mdl-9328222

ABSTRACT

Perinatal exposure of rodents to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) has been shown to result in thymic atrophy and cell-mediated immune suppression at lower doses than are required to produce those effects following adult exposure. This study was designed to examine the effects that in utero TCDD exposure has on thymocyte development in the rat. Timed-bred pregnant F344 rats were given 0, 1.0, or 3.0 mcg TCDD/kg body weight by gavage on gestational day 14 (GD14). On GD19 or GD22/postnatal day one (PD1), the dams were euthanized, and the dams and their offspring were examined for organ weight and thymus phenotypic alterations. GD19 fetuses from the 3.0 mcg TCDD/kg maternal exposure group exhibited decreases in relative thymus weight and thymic cellularity. There were a decreased percentage of CD3-/CD4+ CD8+ thymocytes and an increased percentage of CD3-/CD4-CD8+ thymocytes in these fetuses, but there were no alterations in the CD3+ subsets. No effects were seen in the GD19 fetuses from the 1.0 mcg TCDD/kg dosage group. In the TCDD-exposed GD22/PD1 offspring thymic atrophy was no longer present, but there was an increase in the relative liver weight. In addition, there were decreased percentages of CD3-/CD4-CD8-, CD3+/CD4-CD8-, and CD3+/CD4+CD8+ thymocytes and an increased percentage of CD3+/CD4-CD8+ thymocytes. The CD3+/CD4-CD8- and CD3+/CD4-CD8+ cell populations were the most sensitive, with changes appearing at both 1.0 and 3.0 mcg TCDD/kg maternal exposures. The TCDD-exposed GD19 dams exhibited an increased relative liver weight, a decreased relative thymus weight, and alterations in thymic CD3+ populations. Three days later the relative organ weights had recovered in the dams, but the phenotypic alterations were seen in CD3- as well as CD3+ thymocyte subsets. These results indicate that the developing rat fetal thymus is susceptible to the effects of TCDD. In addition, pregnant rats and their offspring showed similar alterations in thymocytic phenotypes.


Subject(s)
Fetus/drug effects , Immune System/drug effects , Polychlorinated Dibenzodioxins/toxicity , Prenatal Exposure Delayed Effects , Administration, Oral , Animals , Animals, Newborn , Body Weight/drug effects , Embryonic and Fetal Development/drug effects , Female , Flow Cytometry , Immune System/embryology , Organ Size/drug effects , Pregnancy , Rats , Rats, Inbred F344 , T-Lymphocyte Subsets/drug effects , Thymus Gland/cytology , Thymus Gland/drug effects , Thymus Gland/pathology
3.
Toxicology ; 122(3): 229-40, 1997 Oct 19.
Article in English | MEDLINE | ID: mdl-9328223

ABSTRACT

Our recent work showed that in utero 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure produced alterations in fetal and neonatal thymocyte subpopulations. This study was designed to determine the persistence and functional significance of these alterations. One group of timed-bred pregnant F344 rats was dosed with 3.0 mcg TCDD/kg by gavage on gestational day 14 (GD14). The immune function of the perinatally-exposed offspring and age-matched controls were assessed at 14-17 weeks old. Examination of the organ weights and splenic phenotypes showed that TCDD exposure increased the spleen/body weight ratio, decreased the thymus/body weight ratio, and decreased the percentage of splenic CD3+/CD4-CD8- cells in both genders. The delayed-type hypersensitivity (DTH) response to bovine serum albumin (BSA) was suppressed in both the TCDD-exposed males and females. The lymphoproliferative (LP) responses to T-cell and B-cell mitogens and the antibody response to sheep red blood cells were not affected by perinatal TCDD exposure in either gender except for a suppressed LP response to PWM in the females. A second set of timed-pregnant F344 rats was dosed with 0 or 1.0 mcg TCDD/kg on GD14. One day after birth litters were cross-fostered to produce control, placental-only, lactational-only, and placental/lactational exposure groups. The organ weights and thymic and splenic phenotypes of these pups were assayed 1, 2, or 3 weeks post-partum, while the DTH response was assessed in 5-month-old males. Increased liver/body weight ratios, decreased percentages of thymic CD3+/CD4-CD8- cells, and increased percentages of thymic CD3+/CD4-CD8+ cells were seen through 3 weeks old in both genders after TCDD exposure. The severity of the effects was related to the route of exposure (i.e. placental/lactational > lactational > placental). The DTH response to BSA was suppressed in the males receiving both placental and lactational exposure. These results suggest that the immunotoxic effects of perinatal TCDD exposure of rats persist into adulthood and that suppression of the DTH response may represent the most sensitive biomarker for TCDD-induced immunotoxicity in this species.


Subject(s)
Immune System/drug effects , Polychlorinated Dibenzodioxins/toxicity , Administration, Oral , Animals , Antibody Formation/drug effects , Female , Hypersensitivity, Delayed/chemically induced , Immune System/growth & development , Liver/drug effects , Liver/pathology , Lymphocyte Activation/drug effects , Male , Organ Size/drug effects , Pregnancy , Prenatal Exposure Delayed Effects , Rats , Rats, Inbred F344 , Spleen/drug effects , Spleen/pathology , T-Lymphocyte Subsets/drug effects , Thymus Gland/drug effects , Thymus Gland/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...